Abstract:Background Noninvasive methods have been used for the assessment of hepatic steatosis in patients with nonalcoholic fatty liver disease (NAFLD). The aim was to assess the efficacy and accuracy of both magnetic resonance imaging(MRI) and transient elastography(TE) for the evaluation of hepatic steatosis. Materials and Methods The PubMed, Cochrane Library, Embase, MEDLINE and Web of Science databases were searched to retrieve studies examining the accuracy of MRI-proton density fat fraction(PDFF) and TE-controlled attenuation parameter(CAP) for evaluating the grading of steatosis(S0-S3) diagnosed by liver biopsy in NAFLD. We compared the sensitivity, specificity, hierarchical summary receiver operating characteristic curves(HSROC) and clinical utility of these methods. Results Twenty-four articles with a total of 2979 patients with NAFLD were included. The steatosis distribution was 8.1%/35.1%/32.2%/24.6% for S0/S1/S2/S3. For the diagnostic accuracy of MRI-PDFF, the HSROCs were 0.97 for >= S1, 0.91 for >= S2 and 0.90 for >= S3. For the diagnostic accuracy of TE-based CAP, the HSROCs were 0.85 for >= S1, 0.83 for >= S2 and 0.79 for >= S3. Following a 'positive' measurement (over the threshold value) for >= S1, the corresponding post-test probabilities of PDFF and CAP for the presence of steatosis were 82% and 61%, respectively, when the pretest probability was 24%. If the values were below these thresholds ('negative' results), the post-test probabilities were 3% and 7%. Conclusion MRI-PDFF and TE-CAP both provide highly accurate noninvasive approaches for quantifying and staging hepatic steatosis in NAFLD. Compared with TE-CAP, MRI-PDFF is significantly more accurate for evaluating dichotomized grades of steatosis.

Diffuse and focal liver fat: advanced imaging techniques and diagnostic insights

Non-invasive evaluation of liver steatosis with imaging modalities: New techniques and applications

Recent advances in molecular magnetic resonance imaging of liver fibrosis.

The Future Is Beyond Bright: The Evolving Role of Quantitative US for Fatty Liver Disease

Functional Pitch of A Liver: Fatty Liver Disease Diagnosis with Photoacoustic Spectrum Analysis

Role of Imaging Techniques in Clinical Research and Practice on Nonalcoholic Fatty Liver Disease

A meta-analysis on the diagnostic performance of magnetic resonance imaging and transient elastography in nonalcoholic fatty liver disease

Advancements of non‐invasive imaging technologies for the diagnosis and staging of liver fibrosis: Present and future

Update on Imaging-based Noninvasive Methods for Assessing Hepatic Steatosis in Nonalcoholic Fatty Liver Disease

[Research Advances in Diagnosis of Non-Alcoholic Fatty Liver Disease].

Recent Progress in the Molecular Imaging of Nonalcoholic Fatty Liver Disease

Multiparametric quantification and visualization of liver fat using ultrasound

Recent advances in noninvasive assessment of liver steatosis

CT and MR imaging of extrahepatic fatty masses of the abdomen and pelvis: techniques, diagnosis, differential diagnosis, and pitfalls

State-of-the-art imaging of liver fibrosis and cirrhosis: A comprehensive review of current applications and future perspectives

Current aspects of multimodal ultrasound liver diagnostics using contrast-enhanced ultrasonography (CEUS), fat evaluation, fibrosis assessment, and perfusion analysis – An update

Interpretation, Reporting, and Clinical Applications of Liver MR Elastography

Ultrasound Elastography for Characterization of Focal Liver Lesions

New horizon of ultrasound for screening and surveillance of non-alcoholic fatty liver disease spectrum

Ultrasound evaluation of chronic liver disease

Quantification of liver fat using ultrasound technology